Trexquant Investment’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Trexquant Investment's IRMD Position: Q2 2026 in Review
Trexquant Investment increased its iRadimed (IRMD) stake by 217% in Q2 2026, buying an estimated $633K and bringing the position to 10,156 shares worth $971K. The position accounts for 0.01% of the portfolio, ranked #1472.
Trexquant Investment first reported a position in IRMD in Q3 2021 and has held it in 14 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Trexquant Investment held 10,156 shares of iRadimed worth $971K as of Q2 2026.
- Trexquant Investment bought 6,948 iRadimed shares in Q2 2026, an estimated $633K.
- iRadimed made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1472 holding.
- Trexquant Investment first reported a position in iRadimed in Q3 2021 and has held it in 14 quarters since.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.